3-((E)-3-Phenyl-2-propenoyl)-1,3-oxazolidin-2-one, 97%, 100mg

Dibenzo[f,h]quinoxaline, 95.0%, 5g

(4R,4'R)-4,4'-DIPHENYL-4,4',5,5'-TETRAHYDRO-2,2'-BIOXAZOLE, 95%, 1g

6-(trifluoromethyl)-2H-pyrazolo[4,3-b]pyridin-3-amine, 95%, 100mg

1-Boc-4-Ethynylpiperidine, 95.0%, 100g

Electronic laboratory stirrer MICROSTAR control series, 10 l, 8000 mPas, MICROSTAR15 control, 1 piece

1,3-Dibromo-5-pentoxybenzene, 98%, 5g

2-Oxo-2-((3-(3-(piperidin-1-ylmethyl)phenoxy)propyl)amino)ethyl acetate hydrochloride, 98%, 5g

Ethane, 1,2-bis(2-bromoethoxy)-, 97%, 1g

2,3-Dihydroxybenzaldehyde>98.0%(GC)(T)5g

Boc-MeThr(Bzl)-OH, 98%, 5g

(butan-2-yl)[(thiophen-2-yl)methyl]amine, 95.0%, 1g

1-N-Cbz-3-Hydroxyazetidine, 96.0%, 10g